Why One-Time Gene Therapies Are Redefining the Business of Medicine For decades, the pharmaceutical industry has operated under a remarkably consistent economic model. Develop a medicine. Treat patients over many years. Generate recurring clinical benefit and recurring revenue. That model is beginning to change. Gene therapies are introducing an entirely new economic framework, one in which a single treatment has the potential to provide years, or perhaps decades, of clinical
